WASHINGTON, D.C. — Jodie Sweetin told People that her “Full House” co‑star Dave Coulier is “really doing great” after completing treatment for tongue cancer, eight months after the actor announced he was in remission.

Sweetin, who played Stephanie Tanner, said she spent a weekend at Coulier’s home with former cast member Andrea Barber, noting that the actor’s energy and appetite have returned to pre‑diagnosis levels. “He’s laughing, cooking, and just being himself,” Sweetin said, adding that the family’s support network remains strong.

Clinical Context

Tongue cancer, classified as oral cavity squamous cell carcinoma, accounts for roughly 2% of all cancers in the United States. According to the National Cancer Institute, the five‑year survival rate for localized disease is about 85%, but drops to 40% once it spreads to regional lymph nodes. The FDA approved pembrolizumab in 2019 for recurrent or metastatic head‑and‑neck cancers, providing an immunotherapy option that has improved median overall survival to 12.5 months in clinical trials.

• Early detection and surgical resection remain the cornerstone of curative treatment.
• FDA‑approved immunotherapies, such as pembrolizumab, have expanded options for patients with advanced disease.
• Patient‑reported outcomes show higher quality‑of‑life scores when multidisciplinary care includes speech therapy and nutritional support.

Dr. Lisa Hernandez, an oncologist at MD Anderson Cancer Center, explained, “The prognosis for early‑stage oral tongue cancer has improved markedly with the integration of targeted agents and immunotherapy, which can reduce recurrence rates by up to 30% in select patients.” Coulier’s treatment reportedly involved surgical excision followed by a short course of adjuvant radiation and a checkpoint inhibitor.

Since his remission announcement in August 2023, Coulier has participated in several awareness campaigns, emphasizing the importance of routine oral examinations. The American Dental Association recommends a visual oral cancer screening at least once a year for adults over 40, a guideline that could help catch malignancies before they advance.

While Sweetin’s update focuses on Coulier’s personal recovery, the broader impact highlights how celebrity disclosures can drive public health messaging, encouraging early detection and adherence to FDA‑approved treatment protocols.